Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience Academic Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Glioblastoma
  • Neoplasm Recurrence, Local

abstract

  • Survival in our cohort was comparable to the outcome of the defining EORTC-NCIC trial establishing the use of RT+TMZ. This study also identifies several potential prognostic factors that may be useful in stratifying patients.

publication date

  • August 5, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3733728

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0070745

PubMed ID

  • 23940635

Additional Document Info

start page

  • e70745

volume

  • 8

number

  • 8